Synopsys (SNPS) Stock Declines While Market Improves: Some Information for Investors

Synopsys (SNPS) stock recently declined 1.29% to $395.60, underperforming the broader market, and has fallen 10.54% over the past month, trailing its sector and the S&P 500. Ahead of its December 10, 2025 earnings report, the company faces projections for a 17.94% year-over-year EPS drop to $2.79, despite an anticipated 37.59% revenue increase to $2.25 billion. With a Zacks Rank of #3 (Hold), SNPS trades at a premium valuation, featuring a Forward P/E of 28.53 and a PEG ratio of 2.51, both above industry averages.

Analysis

Synopsys (SNPS) has demonstrated significant underperformance recently, with its stock declining 1.29% to $395.60 in the latest session, lagging the S&P 500's 0.21% gain. Over the past month, SNPS shares have fallen 10.54%, considerably trailing both the broader S&P 500 (+4.36%) and its Computer and Technology sector (+6.68%), indicating a moderately negative investor sentiment.

Ahead of its December 10, 2025 earnings report, the company faces a mixed outlook. While the upcoming quarter's revenue is projected to increase by 37.59% year-over-year to $2.25 billion, EPS is anticipated to drop by 17.94% to $2.79. Full-year Zacks Consensus Estimates further project a 2.8% decline in EPS to $12.83, with revenue remaining flat at $7.05 billion, suggesting potential margin compression despite top-line expansion.

Synopsys currently trades at a premium valuation, with a Forward P/E of 28.53 compared to its industry average of 24.64, and a PEG ratio of 2.51 versus the industry's 1.87. The Zacks Consensus EPS estimate has remained unchanged over the last 30 days, contributing to a Zacks Rank of #3 (Hold), which implies a neutral analyst stance on the stock's near-term performance.

Key Decisions for Investors

• Investors should closely monitor the December 10, 2025 earnings report for insights into the company's margin performance and future guidance, given the projected revenue growth but EPS decline.
• Evaluate whether the current premium valuation, indicated by a Forward P/E of 28.53 and PEG ratio of 2.51 relative to industry averages, is justified by future growth prospects or if it presents a risk given the recent stock underperformance.
• Consider the implications of the unchanged Zacks Consensus EPS estimate and the #3 (Hold) Zacks Rank, suggesting a lack of immediate positive catalysts or significant analyst conviction for a strong upward re-rating.